Peptron delays new plant investment completion to H1 2027, increases budget to 89 billion won

Peptron announced a delay in the completion of its new cGMP-grade sustained-release drug production facility investment from December 2026 to June 2027, and an increase in investment amount from 65 billion won to 89 billion won.

“신공장 투자 종료일이 2026년 말에서 2027년 상반기 말로 지연됐다”marketin.edaily.co.kr

• 1 source
• marketin.edaily.co.kr펩트론, 신공장 투자 종료일 2027년 상반기 말로 지연Dec 3, 2025

Summarized from public sources; check the original articles before acting on it.